Serum Proteomic Profiling of Lung Cancer in High-Risk Groups and Determination of Clinical Outcomes

The potential markers that we identified through proteomic fingerprinting could accurately classify lung cancers in a high-risk population and predict survival in a non-small cell lung cancer population.